Literature Review of Criteria for Defining Recipient-Site Infection after Oral Oncologic Surgery with Simultaneous Reconstruction

Surgical Infections

Volumn 18, Issue 7, 2017, Pages 755-764

  Akashi, Masaya ^a   Kusumoto, Junya ^a   Sakakibara, Akiko ^a   Hashikawa, Kazunobu ^a   Furudoi, Shungo ^a   Komori, Takahide ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

flap failure; oral cancer; orocutaneous fistula; recipient site infection; simultaneous reconstruction

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFAZOLIN; CEFEPIME; CEFMETAZOLE; CEFOTIAM; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN; CLINDAMYCIN; LEVOFLOXACIN; METRONIDAZOLE; NETILMICIN; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CANCER SURGERY; HEAD AND NECK INFECTION; HUMAN; INFECTION PREVENTION; INFORMATION RETRIEVAL; MEDLINE; MOUTH CANCER; MOUTH CARCINOMA; NONHUMAN; ORAL FISTULA; ORAL SURGERY; OROCUTANEOUS FISTULA; PRIORITY JOURNAL; RECIPIENT SITE INFECTION; RECONSTRUCTIVE SURGERY; REVIEW; SKIN FISTULA; SURGICAL INFECTION; ADVERSE DEVICE EFFECT; MOUTH NEOPLASMS; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

ANTIBIOTIC PROPHYLAXIS; CUTANEOUS FISTULA; HUMANS; MOUTH NEOPLASMS; RECONSTRUCTIVE SURGICAL PROCEDURES; SURGICAL FLAPS; SURGICAL WOUND INFECTION;

EID: 85030096603     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2017.101     Document Type: Review

References (34)

1. Mazurek MJ, Rysz M, Jaworowski J, et al. Contamination of the surgical field in head and neck oncologic surgery. Head Neck 2014;36:1408-1412.
2. Cunha TF, Soares Melancia TA, Zagalo Fernandes Ribeiro CM, et al. Risk factors for surgical site infection in cervicofacial oncological surgery. J Craniomaxillofac Surg 2012; 40:443-448.
3. Yarlagadda BB, Deschler DG, Rich DL, et al. Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Head Neck 2016;38: E392-E398.
4. Horan TC, Gaynes RP, Martone WJ, et al. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Am J Infect Control 1992;20: 271-274.
5. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999;27:97-132.
6. Johnson JT, Myers EN, Thearle PB, et al. Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope 1984;94:46-51.
7. Hirakawa H, Hasegawa Y, Hanai N, et al. Surgical site infection in clean-contaminated head and neck cancer surgery: Risk factors and prognosis. Eur Arch Otorhinolaryngol 2013;270:1115-1123.
8. Milet PR, Mallet Y, El Bedoui S, et al. Head and neck cancer surgery in the elderly: Does age influence the postoperative course? Oral Oncol 2010;46:92-95.
9. Penel N, Fournier C, Lefebvre D, et al. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa: Study of 260 surgical procedures. Oral Oncol 2005;41:294-303.
10. Sato J, Goto J, Harahashi A, et al. Oral health care reduces the risk of postoperative surgical site infection in inpatients with oral squamous cell carcinoma. Support Care Cancer 2011;19:409-416.
11. Wang CH, Wong YK, Wang CP, et al. Risk factors of recipient site infection in head and neck cancer patients undergoing pectoralis major myocutaneous flap reconstruction. Eur Arch Otorhinolaryngol 2015;272:3475-3482.
12. Lin WJ, Wang CP, Wang CC, et al. The association between surgical site infection and previous operation in oral cavity cancer patients. Eur Arch Otorhinolaryngol 2012;269: 989-997.
13. Liu SA, Wong YK, Wang CP, et al. Surgical site infection after preoperative neoadjuvant chemotherapy in patients with locally advanced oral squamous cell carcinoma. Head Neck 2011;33:954-958.
14. Liu SA, Wong YK, Poon CK, et al. Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope 2007;117:166-171.
15. Akashi M, Furudoi S, Hashikawa K, et al. Postoperative abnormal response of C-reactive protein as an indicator for infectious complications after oral oncologic surgery with primary reconstruction. J Otolaryngol Head Neck Surg 2015;44:13.
16. Candau-Alvarez A, Linares-Sicilia MJ, Dean-Ferrer A, et al. Role of culture of postoperative drainage fluid in the prediction of infection of the surgical site after major oncological operations of the head and neck. Br J Oral Maxillofac Surg 2015;53:200-203.
17. . Pool C, Kass J, Spivack J, et al. Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg 2016;154: 272-278.
18. Wagner JL, Kenney RM, Vazquez JA, et al. Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head Neck 2016;38:1449-1454.
19. Durand ML, Yarlagadda BB, Rich DL, et al. The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope 2015;125: 1084-1089.
20. Kamizono K, Sakuraba M, Nagamatsu S, et al. Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol 2014;21:1700-1705.
21. Lotfi CJ, Cavalcanti Rde C, Costa e Silva AM, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008;138:74-80.
22. Saunders S, Reese S, Lam J, et al. Extended use of perioperative antibiotics in head and neck microvascular reconstruction. Am J Otolaryngol 2017. pii: S0196-0709(16)30468-9.
23. Eder-Czembirek C, Czembirek C, Braun P, et al. Surgical site infection in clean-contaminated wounds after multimodal treatment of advanced oral squamous cell carcinoma. J Craniomaxillofac Surg 2016;44:1957-1962.
24. Lee JI, Kwon M, Roh JL, et al. Postoperative hypoalbuminemia as a risk factor for surgical site infection after oral cancer surgery. Oral Dis 2015;21:178-184.
25. Mücke T, Rohleder NH, Rau A, et al. The value of perioperative antibiotics in the success of oral free flap reconstructions. Microsurgery 2015;35:507-511.
26. Frederick JW, Sweeny L, Carroll WR, et al. Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope 2013;123:1612-1617.
27. Avery CM, Ameerally P, Castling B, et al. Infection of surgical wounds in the maxillofacial region and free flap donor sites with methicillin-resistant Staphylococcus aureus. Br J Oral Maxillofac Surg 2006;44:217-221.
28. Belusic-Gobic M, Car M, Juretic M, et al. Risk factors for wound infection after oral cancer surgery. Oral Oncol 2007; 43:77-81.
29. Tian B, Iyer NG, Tan HK, et al. Novel technique of creating a seal for the vacuum-Assisted closure system application in complex head and neck wounds. Head Neck 2016; 38:E2523-E2526.
30. Dawson C, Gadiwalla Y, Martin T, et al. Factors affecting orocutaneous fistula formation following head and neck reconstructive surgery. Br J Oral Maxillofac Surg 2017;55: 132-135.
31. Guidera AK, Kelly BN, Rigby P, et al. Early oral intake after reconstruction with a free flap for cancer of the oral cavity. Br J Oral Maxillofac Surg 2013;51:224-227.
32. Cloke DJ, Green JE, Khan AL, et al. Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer. Br J Plast Surg 2004;57: 556-560.
33. Sakamoto Y, Yanamoto S, Ota Y, et al. Magnitude of myocutaneous flaps and factors associated with loss of volume in oral cancer reconstructive surgery. J Oral Maxillofac Surg 2016;74:644-649.
34. Ma CY, Ji T, Ow A, et al. Surgical site infection in elderly oral cancer patients: Is the evaluation of comorbid conditions helpful in the identification of high-risk ones? J Oral Maxillofac Surg 2012;70:2445-2452.